ACADIA Pharmaceuticals Inc.
(NASDAQ : ACAD)

( )
ACAD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.32%90.401.3%$812.42m
AMGNAmgen Inc.
-0.03%186.921.2%$635.34m
GILDGilead Sciences, Inc.
0.33%66.980.9%$508.19m
BIIBBiogen Inc.
0.65%335.161.3%$445.14m
ILMNIllumina, Inc.
-0.01%302.243.5%$320.02m
REGNRegeneron Pharmaceuticals, Inc.
0.45%422.512.6%$304.29m
VRTXVertex Pharmaceuticals Incorporated
0.52%187.841.9%$269.00m
ALXNAlexion Pharmaceuticals, Inc.
0.71%129.842.0%$236.61m
SRPTSarepta Therapeutics, Inc.
0.22%140.5715.4%$155.25m
AAgilent Technologies, Inc.
1.28%78.511.6%$145.08m
EXASExact Sciences Corporation
-2.27%83.6325.3%$129.45m
INCYIncyte Corporation
-0.40%83.742.5%$115.31m
ARRYArray BioPharma Inc.
0.30%23.178.2%$109.81m
EXELExelixis, Inc.
-0.52%21.246.4%$84.04m
NBIXNeurocrine Biosciences, Inc.
-1.89%79.365.1%$80.57m

Company Profile

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.